Publications

Bharat L. Agrawal, MD

Agrawal B.L., Agrawal R.S., et al. Metastatic Pulmonary Calcification Causing Hypoxemia in Male Breast Cancer. Journal of Clinical Oncology. (October 2003).

Agrawal B.L., Nath A.R., Glynn Jr TP, et al. Simultaneous Synchronous Bilateral Inflammatory Breast Cancer. Journal of Clinical Oncology. (June 2003).

Yum, M.: Miller, J.C.; Agrawal, B.L.; Leiomyosarcoma Arising in Atypical Fibromuscular Hyperplasia (Phylloides Tumor) of the Prostate with Distant Metastases. CANCER. 68:910-915, 1991.

Gorton, S.J.; Stott, P.B.; Agrawal, B.L.; Bailey, K., and Zelkowitz, L.: Shorter, More Frequent Infusion of 5-Flourouacil (5-FU) with Allopurinol Allows Higher Dose Infusion with Less Toxicity. Submitted to American Society of Clinical Oncology.

Agrawal, B.L.; Foa, R.: A Collegin Vascular Disease Presented as Chorea Gravidarum. Archives of Neurology. 39:192-193, March 1982.

Gorton, S.J.; Stott, P.B.; Agrawal, B.L., and Zelkowitz, L.: Response to Cyclophosphamide and 5-Fluorouracil in Patients Clinically Resistant to Cyclophosphamide, Methotrexate, and 5-Flourouracil. Submitted to the ASCO Journal.

Agrawal, B.L. and Giesen, P.C.: Eosinophilic Myositis: An Unusual Cause of Pseudotumor and Eosinophilia. JAMA. 246:70, July 1981.

Agrawal, B.L.: Ataxia Due Fluoxymesterone Therapy in Breast Cancer. Archives of Internal Medicine. 141:958, June 1981.

Agrawal, B.L., Zelkowitz, L., and Hletko, P: Acute Myocardial Infarction in a Young Hemophiliac Patient During Therapy with Factor IX Concentrate and Epsilon Aminocaproic Acid. Journal of Pediatrics. 98:931-933, 1981.

Agrawal, B.L. Zelkowitz, L.: Bone Flare, Hypercalcemia, and Jaundice After Tamoxifen Therapy. Archives of Internal Medicine. 141:1240, August 1981.

Agrawal, B.L. Unusual Side Effects of Hormonal Therapy. Presented at the American College of Physicians' Meeting in Detroit, Michigan. June 1980.

Gorton, S.J.; Stott, P.B.; Agrawal, B.L., and Zelkowitz, L.: Treatment of Breast Cancer Patients Who Have Failed Bytozan, Methotrexate, and 5-Fluorouracil with Cytoxan & 5-Flourouacil. Proceedings of AACR/ASCO 21, 347, (C-111), 1980. Presented at the 16th Annual Meeting of the American Society of Clinical Oncology, May 26-27, 1980. San Diego, California.

Agrawal, B.L.; Zelkowitz, L., and Hletko, P.: Acute Anterolateral Myocardial Infarction in an Inhibitor Positive Hemophilia-A Patient During Factor IX Concentrate (Konyne) and Epsilon Aminocaproic Acid Therapy. Abstract Circulation, Vol.62, Supp. III-166 (633), October 1980. Presented at the 53rd Scientific Sessions, American Heart Association Fourth National Meeting On Thrombosis and Hemostasis, November 17-20, 1980. Miami, Florida.

Earhart, R.H.; Hamilton, R.D.; Henry, C.S.; Hanover, C.K.; Maile, M.H.; Agrawal, B.L.; and Todd, W.M.: 2-Amino-5Bromo-6Phenyl-4(3HO-Pyrimidinone (ABPP): Phase I Trial of a Well-Tolerated Oral Interferon-Inducing Drug in Cancer Patients. 14th International Congress of Chemotherapy, 1985.

Earhart, R.H.; Hamilton, R.D.; Henry, C.S.; Hanover, C.K.; Maile, M.H.; Agrawal, B.L.; and Todd, W.M.; The Upjohn Company and Bronson Hospital Kalamazoo, MI: Phase I Trial, Pharmacokinetics and Interferon (IFN) Induction of an Oral Divided-Dose Schedule of 2-Amino-5-Brom-6-Phenyl-(3H)-Pyrimidinone (ABPP) in Cancer Patients. Proceedings of the American Association of Cancer Research, 1985.

J. Gaddipati, MD

Gaddipati J, Ahmed T, Friedland M. Prostatic and bladder cancer in the elderly. Clinical Geriatric Medicine 1987 Nov;3(4):649-67. Review. PMID: 3315161 [PubMed - indexed for MEDLINE]

Friedland ML, Bajracharya A, Hodgson WJ, Gaddipati J, Arlin Z. Hepatic abscess following hepatic arterial infusion chemotherapy with an implantable pump. Cancer Invest 1986;4(3):223-4. PMID: 2941114

Arlin ZA, Gaddipati J, Ahmed T, Mittelman A, Friedland M, Rieber E. Treatment of acute leukemia with amsacrine and high-dose cytarabine. Cancer Treatment Reports 1985 Sep;69(9):1001-2. PMID: 3839713

Rieber E, Mittelman A, Wormser GP, Maayan S, Gaddipati J, Ahmed T, Madden K, Chiao JW, Arlin ZA. Vincristine and Kaposi's sarcoma in the acquired immunodeficiency syndrome. Annals of Internal Medicine 1984 Dec;101(6):876. No abstract available. PMID: 6497201

Goyal, V.,Samuel J., et. al. Should Ideal Body Weight or Actual Body Weight Be Used to Calculate Chemotherapy Dose in Obese Patients, Proceeding of ASCO, Vol. 14, March 1994.

Samuel J., Goyal V. Prolonged Survival in Elderly Patients 65 Years and Older with Solid Tumors. Ten Year Retrospective Study. Proceedings of ASCO, Vol 14, March 1995.

Samuel J.,Goyal V. Changing Trends of Primary Malignant Neoplasms in Children. Proceedings of ASCO, Vol. 13, March 1994.

Hans S.S,Masi J.,Goyal V.,Khan T. Increased Blood Loss with In-situ Bypass. The American Surgeon, Vol. 56, No 9:40-542, 1990

Ishizawa, K., Komori, T., Okayama, K., Qin, X., Kaneko, K., Sasaki, S. and Iwata, M. Large motor neuron involvement in Stiff-man syndrome: a qualitative and quantitative study. Acta Neuropathol (Bed) 97:63-70, 1999.

Liu, L., Qin, X. and Gerson, SL. Reduced lung tumorigenesis in human MGMT transgenic mice achieved by expression of transgene within the target cell. Carcinogenesis, 20: 179-284, 1999.

Qin, X., Liu, L. and Gerson, SL. Mice defective in the DNA mismatch gene PMS2 are hypersensitive to MNU induced thymic lymphoma and are partially protected by transgenic expression of human MGMT. Oncogene, 18:4394-4400, 1999.

Qin, X., Zhou, H., Liu, L. and Gerson, SL. Transgenic expression of human MGMT blocks the hypersensitivity ot PMS2-deficient mice to low dose MNU thymic lymphomagenesis. Carcinogenesis, 20:1667-1673,1999.

Qin, X., Shibata, D. and Gerson, SL. Heterozygous DNA mismatch repair gene PMS2 knockout mice are susceptible to intestinal tumor induction with N-methyl­ N-nitrosourea. Carcinogenesis, 21:833-838, 2000.

Qin, X., Zhang, S., Matsukuma, S., Zarkovic, M., Shimizu, S., Ishikawa, T. and Nakatsuru, Y. Protection against malignant progression of spontaneously developing liver tumors in transgenic mice expressing 06-mrthylguanine-DNA methyltransferase. Jpn. J. Cancer Res., 91:1085-1089, 2000.

Reese, JS., Qin, X., Ballas, CB., Sekiguchi, M. and Gerson, SL. MGMT expression in murine bone marrow is a major determinant of animal survival after alkylating agent exposure. J.Hematother. Stem Cell Res., 10:115-123,2001

Ishikawa, T., Ide, F., Qin, X., Takahashi, Y., Sekiguchi, M., Tanaka, K. and Nakatsuru, Y. Importance of DNA repair in carcinogenesis: evidence from transgenic and gene targeting studies. Mutat. Res., 2:477:41-49, 2001.

Liu, L., Spiro, TP., Qin, X., Majka, S., Haaga, J., Schupp, J., WiUson, JK., Gerson, SL. Differential degradation rates of inactivated alkyltransferase in blood mononuclear cells and tumors of patients after treatment with O(6)-benzylguanine. Clin Cancer Res., 7: 2318-2324,2001.

Zhou, H., Chen, W.D., Qin, X., Lee, K., Liu, L., Markowitz, S.D. and Gerson, S.L. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice. Oncogene, 20: 6009-6017, 2001.

Zhou, H., Liu, L., Lee, K., Qin, X., Grasso, AW., Kung, HJ., Willis, IE., Kern, J., Wagner, T. and Gerson, SL. Lung tumorigenesis associated with erb-B-2 and erb-B-3 overexpression in human erb-B-3 transgenic mice is enhanced by methylnitrosourea. Oncogene, 22:8732-8740, 2002.

Ishikawa, T., Zhang, SS., Qin, X., Takahashi, Y., Oda, H., Nakatsuru, Y. and Ide, F. DNA repair and cancer: lessons from mutant mouse models. Cancer Sci.,95(2):112-117,2004